Search
Now showing items 11-20 of 22
Compositions containing C-substituted diindolylmethane compounds
(United States. Patent and Trademark Office, 2007-06-19)
Disclosed are methods and compositions for the treatment of a wide array of cancers and tumors. In illustrative embodiments, diindolylmethanes, C-substituted diindolylmethanes, and analogs thereof have been described, which ...
Compounds and methods for the treatment of cancer
(United States. Patent and Trademark Office, 2012-07-17)
The present invention provides organic arsenicals which may be used to treat numerous human tumor cell lines, both of solid and hematological origin, as well as against malignant blood cells from patients with leukemia.
Potent immunosuppressive agents, derivatives and uses
(United States. Patent and Trademark Office, 2014-09-23)
Provided herein include compositions, all related stereoisomers as well as pharmaceutically acceptable salts provided as simplified analogs of pateamine A, in which the analogs generally are devoid of the C3-amino and ...
Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
(United States. Patent and Trademark Office, 2007-10-09)
The present invention involves a recombinant virus which comprises at least one foreign nucleic acid inserted within a non-essential region of the viral genome of a virus, wherein each such foreign nucleic acid encodes a ...
Belactosin derivatives as therapeutic agents/biological probes and their synthesis
(United States. Patent and Trademark Office, 2012-02-21)
Derivatives of belactosin and their synthesis are disclosed. In certain embodiments, compounds of the present invention exhibit anti-cancer, antiviral, antibiotic, and/or auto-immune therapeutic abilities. In general, ...
C-substituted diindolylmethane compositions and methods for the treatment of multiple cancers
(United States. Patent and Trademark Office, 2012-04-03)
The present embodiment of the invention is generally directed to compositions comprising suspensions of poorly water soluble compounds recrystallized in nanoparticulate sizes ranging from 0.1 to 5 ?m. In addition, the ...
Cancer treatment targeting non-coding RNA overexpression
(United States. Patent and Trademark Office, 2015-02-17)
Provided herein are methods directed to modulating the pro-oncogenic effects of noncoding RNAs (ncRNAs) through their interactions with specificity protein transcription factors (SpTFs). In one aspect, the disclosure ...
S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
(United States. Patent and Trademark Office, 2009-11-17)
Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of ...
S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
(United States. Patent and Trademark Office, 2006-02-07)
Arsenic trioxide, an inorganic compound, is commercially available anti-cancer agent but it carries significant toxicity. Organic arsenicals, on the other hand, are much less toxic, to the extent that the methylation of ...
Specific binding sites in collagen for integrins and use thereof
(United States. Patent and Trademark Office, 2012-08-28)
The present invention identified a high affinity binding sequence in collagen type III for the collagen-binding integrin I domains. Provided herein are the methods used to characterize the sequence, the peptides comprising ...